The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(2-(Cyclopropanecarboxamido)isonicotinamido)-N-((1-(2-methylbenzyl)piperidin-4-yl)methyl)nicotinamide ID: ALA4872690
PubChem CID: 164619065
Max Phase: Preclinical
Molecular Formula: C30H34N6O3
Molecular Weight: 526.64
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccccc1CN1CCC(CNC(=O)c2cncc(NC(=O)c3ccnc(NC(=O)C4CC4)c3)c2)CC1
Standard InChI: InChI=1S/C30H34N6O3/c1-20-4-2-3-5-24(20)19-36-12-9-21(10-13-36)16-33-28(37)25-14-26(18-31-17-25)34-30(39)23-8-11-32-27(15-23)35-29(38)22-6-7-22/h2-5,8,11,14-15,17-18,21-22H,6-7,9-10,12-13,16,19H2,1H3,(H,33,37)(H,34,39)(H,32,35,38)
Standard InChI Key: QHSNOGOBQIARBJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
8.2398 -31.1067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9346 -30.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6587 -31.0632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3576 -30.6289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9095 -29.8556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0817 -31.0196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1048 -31.8423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8248 -32.2289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5262 -31.8022 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5031 -30.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7784 -30.5850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2488 -32.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9494 -31.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6670 -32.1554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3671 -31.7285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3455 -30.9066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6179 -30.5134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9250 -30.9467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5245 -30.7173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8302 -31.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8549 -31.9644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5798 -32.3507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2711 -31.9190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1104 -30.7597 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4154 -31.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6957 -30.8025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6726 -29.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9537 -29.5987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2577 -30.0286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2851 -30.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0045 -31.2328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5916 -31.2818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8705 -30.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1837 -31.3296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8429 -30.0806 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3614 -31.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7958 -32.0552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6867 -32.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4401 -32.0063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
2 5 2 0
4 6 1 0
6 7 1 0
6 11 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
9 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
1 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 1 1 0
20 24 1 0
24 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
30 32 1 0
32 33 1 0
33 34 1 0
33 35 2 0
36 34 1 0
37 36 1 0
34 37 1 0
14 38 1 0
25 39 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 526.64Molecular Weight (Monoisotopic): 526.2692AlogP: 4.03#Rotatable Bonds: 9Polar Surface Area: 116.32Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.93CX Basic pKa: 9.23CX LogP: 3.04CX LogD: 1.22Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.39Np Likeness Score: -1.78
References 1. Jiang X, Liu C, Zou M, Xie H, Lin T, Lyu W, Xu J, Li Y, Feng F, Sun H, Liu W.. (2021) Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine., 223 [PMID:34198150 ] [10.1016/j.ejmech.2021.113663 ]